King Pharmaceuticals KG Workers' Compensation — Year 2
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearTwo.
The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's workers' compensation — year 2.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is King Pharmaceuticals's workers' compensation — year 2?
- King Pharmaceuticals (KG) reported workers' compensation — year 2 of 32.5% in Q4 2025.
- What does workers' compensation — year 2 mean?
- This metric tracks the financial performance or claim activity for the second year of the workers' compensation policy cycle. It provides insight into the maturation of claims and the accuracy of initial loss estimates made in the first year. Analyzing this data is critical for understanding the development of loss ratios over time.